跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
INTAXEL INJECTION 6 MG/ML - HSA Drug Approval Details
Approvals
/
HSA
/
INTAXEL INJECTION 6 MG/ML
Approved
THERAPEUTIC
INTAXEL INJECTION 6 MG/ML
FRESENIUS KABI ONCOLOGY LIMITED - INDIAFRESENIUS KABI ONCOLOGY LIMITED (BADDI II) (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Feb 6, 2006
Approval ID
0f012e888326174a
Company
FRESENIUS KABI ONCOLOGY LIMITED - INDIAFRESENIUS KABI ONCOLOGY LIMITED (BADDI II) (INDIA)
Type
Therapeutic
Approval Details
Approval Id
0f012e888326174a
Drug Name
INTAXEL INJECTION 6 MG/ML
Product Name
INTAXEL INJECTION 6 MG/ML
Approval Number
SIN13180P
Approval Date
2006-02-06
Registrant
FRESENIUS KABI (SINGAPORE) PTE LTD
Licence Holder
FRESENIUS KABI (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, SOLUTION, CONCENTRATE
Route Of Administration
INTRAVENOUS
Atc Code
L01CD01
Atc Item Name
paclitaxel
Pharma Manufacturer Name
FRESENIUS KABI (SINGAPORE) PTE LTD
Active Ingredients
PACLITAXEL
6.0 mg/ml
PACLITAXEL
6.0 mg/ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 6, 2006
Approval ID
0f012e888326174a
Type
Therapeutic
Back to HSA Approvals